MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis

Early identification of individuals with colorectal cancer who are at high risk of metastasis might help guide treatment choice and improve outcome. Stein et al . now report that MACC1 , a previously undescribed gene, is a prognostic indicator of colorectal cancer and describe its role as a transcri...

Full description

Saved in:
Bibliographic Details
Published inNature medicine Vol. 15; no. 1; pp. 59 - 67
Main Authors Stein, Ulrike, Walther, Wolfgang, Arlt, Franziska, Schwabe, Holger, Smith, Janice, Fichtner, Iduna, Birchmeier, Walter, Schlag, Peter M
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.01.2009
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Early identification of individuals with colorectal cancer who are at high risk of metastasis might help guide treatment choice and improve outcome. Stein et al . now report that MACC1 , a previously undescribed gene, is a prognostic indicator of colorectal cancer and describe its role as a transcriptional regulator of MET , which encodes the hepatocyte growth factor receptor and promotes metastasis of a variety of cancers. We identified a previously undescribed gene associated with colon cancer by genome-wide expression analysis in primary and metastatic carcinomas: metastasis-associated in colon cancer-1, MACC1 . MACC1 expression in tumor specimens is an independent prognostic indicator of metastasis formation and metastasis-free survival. We show that the gene encoding the hepatocyte growth factor (HGF) receptor, MET , is a transcriptional target of MACC1. MACC1 promotes proliferation, invasion and HGF-induced scattering of colon cancer cells in cell culture and tumor growth and metastasis in mouse models. These phenotypes are lost in cells expressing MACC1 mutants lacking the SH3 domain or the proline-rich motif. For clinical practice, MACC1 will be useful for the identification of poor prognosis subjects with colorectal cancer and is a promising new target for intervention in metastasis formation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1078-8956
1546-170X
1546-170X
DOI:10.1038/nm.1889